Search

Gary S Gilkeson

from Charleston, SC
Age ~71

Gary Gilkeson Phones & Addresses

  • 843 Whispering Marsh Dr, Chas, SC 29412 (843) 406-4910 (843) 406-4911
  • Charleston, SC
  • Easley, SC
  • Athens, GA
  • Washington, DC
  • Durham, NC
  • Cary, NC
  • 843 Whispering Marsh Dr, Charleston, SC 29412 (843) 478-2441

Work

Company: MUSC Rheumatology Address: 135 Rutledge St Suite 503, Charleston, SC 29425 Phones: (843) 792-1991

Education

School / High School: University Of Texas Southwestern Medical Center At Dallas 1979

Languages

English • Spanish

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 1982

Emails

Specialities

Rheumatology

Professional Records

Medicine Doctors

Gary Gilkeson Photo 1

Dr. Gary S Gilkeson, Charleston SC - MD (Doctor of Medicine)

View page
Specialties:
Rheumatology
Address:
MUSC Rheumatology
135 Rutledge St Suite 503, Charleston, SC 29425
(843) 792-1991 (Phone)

MUSC Rheumatology
96 Jonathan Lucas St Suite 912, Charleston, SC 29425
(843) 792-1991 (Phone)

MUSE Rheumatology
96 Jonathan Lucas St Suite 912, Charleston, SC 29425
(843) 876-0500 (Phone)

Medical University of SC RHU
96 Jonathan Lucas St Suite 912, Charleston, SC 29425
(843) 792-9200 (Phone)

171 Ashley Ave, Charleston, SC 29425
(843) 792-1414 (Phone)
Procedures:
Joint Drainage
Myofascial Trigger Point Injection
Trigger Point Injections
Viscosupplementation With Hyaluronate
Conditions:
Adhesive Capsulitis
Antiphospholipid Syndrome (APS)
Arthritis
Behçet's Disease
Bursitis
Carpal Tunnel Syndrome
Chronic Neck Pain
Classic Polyarteritis Nodosa
Degenerative Disc Disease
Dermatomyositis
Enthesopathy of Hip (incl. Trochanteric Bursitis)
Fibromyalgia
Giant Cell Arteritis
Gout
Immune Thrombocytopenic Purpura (ITP)
Low Back Pain
Lupus Erythematosus
Osteoarthritis
Osteoarthritis of Hand or Wrist
Osteoarthritis of Hip
Osteoarthritis of Knee
Osteoarthritis of Spine
Osteopenia
Osteoporosis
Patellofemoral Pain Syndrome or Knee Pain
Polymyalgia Rheumatica (PMR)
Polymyositis
Raynaud's Disease
Reiter's Syndrome (Reactive Arthritis)
Rheumatoid Arthritis
Sarcoidosis
Sjögren's Syndrome
Spondylitis
Still's Disease
Systemic Lupus Erythematosus (SLE)
Systemic Sclerosis
Systemic Vasculitis
Takayasu's Arteritis
Vasculitis
Wegener's Granulomatosis
Certifications:
Internal Medicine, 1982
Rheumatology, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Spanish
Hospitals:
MUSC Rheumatology
135 Rutledge St Suite 503, Charleston, SC 29425

MUSC Rheumatology
96 Jonathan Lucas St Suite 912, Charleston, SC 29425

171 Ashley Ave, Charleston, SC 29425

MUSE Rheumatology
96 Jonathan Lucas St Suite 912, Charleston, SC 29425

Medical University of SC RHU
96 Jonathan Lucas St Suite 912, Charleston, SC 29425

Musc Medical Center
169 Ashley Avenue, Charleston, SC 29425
Education:
Medical School
University Of Texas Southwestern Medical Center At Dallas
Graduated: 1979
Medical School
U Nc Affil Hosps
Graduated: 1979
Medical School
Duke University Med Center
Graduated: 1979
Medical School
University Of Nc Hosps
Graduated: 1979
Medical School
Duke University Hospital
Graduated: 1979
Gary Gilkeson Photo 2

Gary S. Gilkeson

View page
Specialties:
Rheumatology
Work:
University Medical AssociatesMedical University Of South Carolina Rheumatology
135 Rutledge Ave, Charleston, SC 29425
(843) 792-9200 (phone), (843) 792-7121 (fax)

University Medical AssociatesMedical University Of South Carolina Rheumatology
96 Jonathan Lucas St, Charleston, SC 29425
(843) 792-1991 (phone), (843) 792-2995 (fax)
Education:
Medical School
University of Texas Southwestern Medical Center at Dallas
Graduated: 1979
Procedures:
Arthrocentesis
Conditions:
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Acute Renal Failure
Alopecia Areata
Anemia
Languages:
English
Spanish
Description:
Dr. Gilkeson graduated from the University of Texas Southwestern Medical Center at Dallas in 1979. He works in Charleston, SC and 1 other location and specializes in Rheumatology. Dr. Gilkeson is affiliated with Medical University Of South Carolina and Ralph H Johnson VA Medical Center.
Gary Gilkeson Photo 3

Gary Steven Gilkeson, Charleston SC

View page
Specialties:
Internal Medicine
Rheumatology
Work:
Medical University of South Carolina
96 Jonathan Lucas St, Charleston, SC 29425
Medical University of South Carolina
171 Ashley Ave, Charleston, SC 29425
Education:
The University of Texas Southwestern (1979)
Gary Gilkeson Photo 4

Gary S Gilkeson, Charleston SC

View page
Specialties:
Rheumatologist
Address:
171 Ashley Ave, Charleston, SC 29425
Education:
University of Texas, Southwestern Medical School (Dallas) - Doctor of Medicine
Duke University Hospital - Fellowship - Rheumatology (Internal Medicine)
North Carolina Children's Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)

Resumes

Resumes

Gary Gilkeson Photo 5

Professor At Medical University Of South Carolina

View page
Location:
169 Ashley Ave, Charleston, SC 29401
Industry:
Hospital & Health Care
Work:
Medical University of South Carolina
Professor at Medical University of South Carolina
Gary Gilkeson Photo 6

Gary Gilkeson

View page
Work:
Medical University of South Carolina
Professor of Medicine

Medical University of South Carolina
Professor

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gary Gilkeson
Director
LUPUS FOUNDATION OF AMERICA, INC
Other Services
11786 Coorsgold Ln, Porter Ranch, CA 91326
2000 L St NW STE 410, Washington, DC 20036
5400 Big Tyler Rd, Charleston, WV 25313
2000 L St Nw  Suite 410, Washington, DC 20036
(202) 349-1155
Gary S. Gilkeson
Rheumatology Specialist
Medical University of South Carolina
Gynecology Services · Medical Doctor's Office
96 Jonathan Lucas St, Charleston, SC 29425
Gary Gilkeson
LUPUS FOUNDATION OF AMERICA, INC
2000 L St NW, Washington, DC 20036
124 W Capitol Ave STE 1900, Little Rock, AR 72201
Gary Steven Gilkeson
Gary Gilkeson MD
Internist
96 Jonathan Lucas St, Charleston, SC 29425
(843) 792-9200
Gary S. Gilkeson
Director
Lupus Foundation of America, DC/MD/VA Chapter
Nonprofit Organization Management · Individual/Family Services
2000 L Street, NW SUITE 415, Washington, DC 20036
2000 L St NW, Washington, DC 20036
(202) 349-1167, (202) 223-1970

Publications

Us Patents

Targeting Complement Factor H For Treatment Of Diseases

View page
US Patent:
7759304, Jul 20, 2010
Filed:
Jun 21, 2007
Appl. No.:
11/821370
Inventors:
Gary Gilkeson - Charleston SC, US
Stephen Tomlinson - Mount Pleasant SC, US
V. Michael Holers - Denver CO, US
Baerbel Rohrer - Mount Pleasant SC, US
Assignee:
Regents of the University of Colorado - Boulder CO
MUSC Foundation For Research Development - Charleston SC
International Classification:
C07K 14/00
US Classification:
514 2, 530350, 4353201, 435325
Abstract:
The invention provides a CR2-FH molecule comprising a CR2 portion comprising CR2 protein or a fragment thereof and a FH portion comprising a factor H protein or a fragment thereof, and pharmaceutical compositions comprising a CR2-FH molecule. Also provided are methods of using the compositions for treatment diseases in which the alternative complement pathway is implicated, such as age-related macular degeneration, rheumatoid arthritis, and ischemia reperfusion.

Anti-Factor B Antibodies

View page
US Patent:
7999082, Aug 16, 2011
Filed:
Feb 10, 2005
Appl. No.:
11/057047
Inventors:
Vernon Michael Holers - Denver CO, US
Joshua M. Thurman - Greenwood Village CO, US
Christian Taube - Denver CO, US
Erwin W. Gelfand - Englewood CO, US
Gary Steven Gilkeson - Charleston SC, US
Assignee:
National Jewish Medical and Research Center - Denver CO
MUSC Foundation for Research Development - Charleston SC
The Regents of the University of Coloraodo - Boulder CO
International Classification:
C07K 16/36
C07K 16/00
A61K 39/395
US Classification:
53038825, 5303871, 5303873, 5303881, 5303882, 4241301, 4241331, 4241411, 4241451, 4241581
Abstract:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.

Targeting Complement Factor H For Treatment Of Diseases

View page
US Patent:
8569225, Oct 29, 2013
Filed:
May 18, 2010
Appl. No.:
12/782526
Inventors:
Gary Gilkeson - Charleston SC, US
Stephen Tomlinson - Mount Pleasant SC, US
V. Michael Holers - Denver CO, US
Baerbel Rohrer - Mount Pleasant SC, US
Assignee:
MUSC Foundation for Research Development - Charleston SC
The Regents of the University of Colorado, a body corporate - Denver CO
International Classification:
C07K 14/00
C12N 15/00
US Classification:
514 1, 530350, 4353201, 435325
Abstract:
The invention provides a CR2-FH molecule comprising a CR2 portion comprising CR2 protein or a fragment thereof and a FH portion comprising a factor H protein or a fragment thereof, and pharmaceutical compositions comprising a CR2-FH molecule. Also provided are methods of using the compositions for treatment diseases in which the alternative complement pathway is implicated, such as age-related macular degeneration, rheumatoid arthritis, and ischemia reperfusion.

Inhibition Of Factor B, The Alternative Complement Pathway And Methods Related Thereto

View page
US Patent:
20080075720, Mar 27, 2008
Filed:
Aug 3, 2007
Appl. No.:
11/888997
Inventors:
Vernon Holers - Denver CO, US
Joshua Thurman - Greenwood Village CO, US
Christian Taube - Denver CO, US
Erwin Gelfand - Englewood CO, US
Gary Gilkeson - Charleston SC, US
International Classification:
C07K 16/46
A61K 39/395
A61P 11/06
US Classification:
424134100, 530391100
Abstract:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.

Inhibition Of Factor B, The Alternative Complement Pathway And Methods Related Thereto

View page
US Patent:
20080102040, May 1, 2008
Filed:
Aug 22, 2007
Appl. No.:
11/843617
Inventors:
V. Holers - Denver CO, US
Joshua Thurman - Greenwood Village CO, US
Christian Taube - Denver CO, US
Erwin Gelfand - Englewood CO, US
Gary Gilkeson - Charleston SC, US
International Classification:
A61K 9/14
A61K 39/395
A61P 11/02
US Classification:
424046000, 424130100
Abstract:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.

Inhibition Of Factor B, The Alternative Complement Pathway And Methods Related Thereto

View page
US Patent:
20140154307, Jun 5, 2014
Filed:
Feb 18, 2014
Appl. No.:
14/183213
Inventors:
- Charleston SC, US
- Denver CO, US
Erwin W. Gelfand - Englewood CO, US
Gary Steven Gilkeson - Charleston SC, US
Assignee:
MUSC Foundation for Research Development - Charleston SC
National Jewish Health - Denver CO
The Regents of the University of Colorado, a body corporate - Denver CO
International Classification:
C07K 16/18
A61K 45/06
A61K 39/395
US Classification:
424450, 5303879, 5303873, 4241391
Abstract:
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.
Gary S Gilkeson from Charleston, SC, age ~71 Get Report